With operations in the US and UK: Acidophil semi-serially creates, develops, manages, finances and commercializes new products and businesses in human health, agriculture, and animal health based upon biotechnologies including molecular biology, chemistry and related information technologies. In 2014, Acidophil co-founded AgriMetis (www.agrimetis.com) with Syngenta Ventures to develop innovative crop protection products, it then provided management and participated in rounds of investment.
|Address:||20 Station Road, Suite 103, Cambridge|
|Membership type:||Agri-Tech East membership|
No company profile has been set for Acidophil.